1 min read
SCOPE: Powering the Future of Clinical Research
Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
🔬 Advancing Clinical Research with...
1 min read
Join Veristat and hundreds of Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the northeast region for the Clinical Operations in Oncology Trials East 2017 Conference.
Our experts at this conference will explore strategies and review success stories of optimizing clinical processes within oncology trials to ensure effective patient recruitment, trial management and overall trial success.
Key topics of discussion will include:
- Designing effective patient retention schemes for clinical trials on a national and international scale to ensure trial efficiency
- Considering a patients perspective and best practice when building trial protocol with a patient centric focus for success within your clinical trials
- Case Studies: Implementing Risk-based Monitoring (RBM) in Oncology Trials to Enhance Patient Safety & Study Quality
- Understanding the impact of foreign regulat
- ions and guidance’s when conducting global clinical trials in Oncology
- Aligning clinical trials with the correct placement; site optimization for maximum trial outcome
- Examining how to gain competitive advantage for your trial through site engagement and commitment
- Exploring personalized medicine and targeted therapy within Oncology and understanding operational logistics to effectively build protocol design
Stop by Our Booth #17
Meet up with Veristat at booth # 17. Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more. Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.
Schedule a time to speak with Veristat at the event on how we can put our oncology clinical trial and regulatory submission experience to work for you. Fill out the form on the right.